AFG
VRTX icon

Atomi Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Atomi Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03M Sell
6,108
-558
-8% -$247K 0.08% 191
2026
Q1 		$2.98M Buy
6,666
+125
+2% +$58.3K 0.09% 177
2025
Q4 		$2.97M Buy
6,541
+4,157
+174% +$1.79M 0.09% 175
2025
Q3 		$934K Sell
2,384
-141
-6% -$58.9K 0.03% 401
2025
Q2 		$1.12M Sell
2,525
-318
-11% -$147K 0.04% 308
2025
Q1 		$1.38M Buy
2,843
+664
+30% +$309K 0.06% 228
2024
Q4 		$877K Buy
2,179
+262
+14% +$121K 0.04% 302
2024
Q3 		$892K Buy
1,917
+827
+76% +$397K 0.06% 269
2024
Q2 		$511K Buy
1,090
+208
+24% +$90.3K 0.04% 391
2024
Q1 		$369K Buy
882
+156
+21% +$65.9K 0.03% 452
2023
Q4 		$295K Buy
+726
New +$268K 0.04% 423

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Atomi Financial Group's VRTX Position: Q2 2026 in Review

Atomi Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 8.4% in Q2 2026, selling an estimated $247K and leaving 6,108 shares worth $3.03M. The position accounts for 0.08% of the portfolio, ranked #191.

Atomi Financial Group first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Atomi Financial Group held 6,108 shares of Vertex Pharmaceuticals worth $3.03M as of Q2 2026.
  • Atomi Financial Group sold 558 Vertex Pharmaceuticals shares in Q2 2026, an estimated $247K.
  • Vertex Pharmaceuticals made up 0.08% of Atomi Financial Group's portfolio in Q2 2026, its #191 holding.
  • Atomi Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.